Open AccessCardiovascular Ischemic Event Rates in Outpatients With Symptomatic Atherothrombosis or Risk Factors in the United States
Author(s) -
Kim A. Eagle,
Alan T. Hirsch,
Robert M. Califf,
Mark J. Alberts,
Philippe Gabriel Steg,
Christopher P. Can,
Danielle M. Brennan,
Deepak L. Bhatt
Publication year - 2009
Publication title -
critical pathways in cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.372
H-Index - 24
eISSN - 1535-282X
pISSN - 1535-2811
DOI - 10.1097/hpc.0b013e3181a84613
Subject(s) - medicine , myocardial infarction , dyslipidemia , stroke (engine) , population , coronary artery disease , cardiology , risk factor , disease , proportional hazards model , mechanical engineering , environmental health , engineering
Atherothrombosis, defined as coronary artery, cerebrovascular, and peripheral arterial disease, is the leading cause of death in the United States. Limited data are available from outpatient populations to describe contemporary cardiovascular ischemic event rates and associated use of risk reduction treatments in patients with clinically manifest, or at risk for, atherothrombosis. The REduction of Atherothrombosis for Continued Health (REACH) Registry is an international, prospective, observational study of patients with either documented atherothrombotic syndromes or 3 or more risk factors designed to fill this knowledge gap.